In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20 percent of their body weight, on average, a result that caused the Danish company’s ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

India’s apex drug regulating authority, the Central Drugs Standard Control Organisation (CDSCO), has approved 19 new drugs so ...

Alison Hammond has opened up about her impressive 11-stone weight loss, revealing she achieved it without using Ozempic. The 49-year-old This Morning presenter decided to shed the pounds following ...

People who use Ozempic or Wegovy for weight loss often find they must avoid certain foods to minimize side effects from the medications. Both drugs contain semaglutide, a synthetic version of a ...

Ozempic maker Novo Nordisk saw its value fall by as much as £82billion yesterday after a weight loss drug trial fell short of expectations. It was one of the Danish pharma giant's worst days on ...

According to its website, Novo Nordisk was founded in 1923 in Copenhagen, Denmark’s capital city. It is best known for manufacturing diabetes medications, including Ozempic and Wegovy. Ozempic is used ...

It's been one year since I started taking Ozempic and it has changed my life. I was diagnosed with type two diabetes in 2016, following a lifetime of emotional eating. Sugar was my best friend ...

The Ozempic-maker's stock plunged 21% to trade at $82.03 per share shortly after the opening bell on Friday morning, hitting its lowest level in over a year. The losses come after the Danish ...

It comes after the National Pharmacy Association (NPA) suggested there could be an "explosion in the unlicensed sale of medication online" because of a shortage of the Diabetes medication Ozempic.

The new 1.2 GHz NMR complements the existing 800 MHz NMR in Basel and other high-field NMRs for protein structure determination, measurement of protein dynamics ... analytical and diagnostic solutions ...

The European Union’s drug regulator said it would review a potential link between Novo Nordisk’sNOVO.B-1.84%decrease; red down pointing triangle blockbuster diabetes drug, Ozempic, and a rare ...